ZFIN ID: ZDB-FISH-150901-24754
Fish name: zf5Tg
Genotype: zf5Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by zf5Tg
Human Disease Conditions Citations
diabetes mellitus chemical treatment: alloxan Nam et al., 2015
GENE EXPRESSION
Gene expression in zf5Tg
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab2-isl control Fig. 2 with image from Xu et al., 2016
Ab1-ins standard conditions Figure 1 with image from Mullapudi et al., 2018
Fig. 1 from Mazilu et al., 2010
PHENOTYPE
Phenotype in zf5Tg
Phenotype Conditions Figures
endocrine pancreas pancreatic B cell increased amount, abnormal chemical treatment by environment: LY-411575 Fig. 1Fig. 5 from Liu et al., 2017
endocrine pancreas pancreatic B cell increased amount, exacerbated chemical treatment by environment: LY-411575, chemical treatment by environment: (R)-DRF053 hydrochloride hydrate Fig. 1Fig. 5 from Liu et al., 2017
endocrine pancreas pancreatic B cell increased amount, exacerbated chemical treatment by environment: LY-411575, chemical treatment by environment: seliciclib Fig. 1 from Liu et al., 2017
pancreas GFP expression decreased amount, abnormal chemical treatment by environment: hexadecanoic acid Fig. 2 from Cha et al., 2018
pancreas decreased size, abnormal chemical treatment by environment: alloxan Fig. 3 from Kwon et al., 2017
pancreas has normal numbers of parts of type pancreatic B cell, normal chemical treatment: N-ethyl-5'-carboxamidoadenosine Fig. 3 with image from Andersson et al., 2012
pancreas has normal numbers of parts of type pancreatic B cell, normal chemical treatment: N-ethyl-5'-carboxamidoadenosine Fig. 3 with image from Andersson et al., 2012
pancreas has normal numbers of parts of type pancreatic B cell, normal control Fig. 3 with image from Andersson et al., 2012
pancreas size, ameliorated chemical treatment by environment: isonitramine, chemical treatment by environment: alloxan Fig. 3 from Kwon et al., 2017
pancreatic B cell GFP expression increased amount, abnormal chemical treatment by environment: 3,3',5'-triiodothyronine Fig. 2 from Matsuda et al., 2017
type B pancreatic cell proliferation occurrence, normal chemical treatment: N-ethyl-5'-carboxamidoadenosine Fig. 3 with image from Andersson et al., 2012
type B pancreatic cell proliferation occurrence, normal control Fig. 3 with image from Andersson et al., 2012
type B pancreatic cell proliferation occurrence, normal chemical treatment: N-ethyl-5'-carboxamidoadenosine Fig. 3 with image from Andersson et al., 2012

CITATIONS  (32)